We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

Fund managers haven’t disclosed any holdings of ARIA yet.

ARIA Hedge Fund Activity: Q2 2017 in Review

0 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q2 2017, worth a combined $0 — down 100% from $34.3M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ARIA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was FNY Partners Fund, exiting entirely with an estimated $34.3M sold.

  • 0 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q2 2017, down from 1 in Q1 2017.
  • Funds reported $0 of Ariad Pharmaceuticals Inc stock for Q2 2017, down 100% quarter-over-quarter.
  • 0 funds opened new Ariad Pharmaceuticals Inc positions in Q2 2017 and 1 closed out, a net change of -1 holder.
  • The largest Ariad Pharmaceuticals Inc seller in Q2 2017 was FNY Partners Fund, an estimated $34.3M sold.

Based on aggregated 13F filings for Q2 2017.